Ascenta Capital's book
8 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Tubulis | Drug Discovery | $5.8B | — | — | |
| Cardurion | Biotechnology | $760.0M | — | — | |
| Iambic | — | $648.0M | — | — | |
| Odyssey Therapeutics | Biotechnology | $638.2M | — | — | |
| OrsoBio | — | $310.0M | — | — | |
| TRIANA Biomedicines | Discovery Tools (Healthcare) | $258.0M | — | — | |
| Angitia Biopharmaceuticals | Drug Discovery | — | — | — | |
| Alpha-9 Oncology | Biotechnology | — | — | — |
Free account
See the whole book
- ·Watchlist + alerts for Ascenta Capital's activity
Create free account
No card required